Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 14 to 33 of 117 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Beneficial effects of omega-3 fatty acids: the current evidenceGazi, I.; Liberopoulos, E. N.; Saougos, V. G.; Elisaf, M. S.24-Nov-2015-
Clinical use of Nebivolol in the treatment of chronic heart failureLiberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceTsouli, S. G.; Liberopoulos, E. N.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase ARizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)Liberopoulos, E. N.; Florentin, M.; Kei, A.; Mountzouri, E.; Agouridis, A.; Elisaf, M. S.24-Nov-2015-
Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemiaBairaktari, E. T.; Tzallas, C. S.; Tsimihodimos, V. K.; Liberopoulos, E. N.; Miltiadous, G. A.; Elisaf, M. S.24-Nov-2015-
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortalityLiberopoulos, E. N.; Florentin, M.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients?Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Could statins be useful in the treatment of patients with migraine?Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015-
Cryoglobulinemic purpura in visceral leishmaniasisRizos, E.; Dimos, G.; Liberopoulos, E. N.; Elisaf, M. S.; Drosos, A. A.24-Nov-2015-
Diagnosis and management of the metabolic syndrome in obesityLiberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Diagnosis of the metabolic syndrome: which definition should we use?Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J.; Athyros, V. G.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Diverging trends in cardiovascular morbidity and mortality in a low risk populationChimonas, T.; Fanouraki, I.; Liberopoulos, E. N.; Chimonas, E.; Elisaf, M. S.24-Nov-2015-
Do statins have an antiarrhythmic activity?Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Drug combinations for dyslipidemia and obesity treatment in metabolic syndromeFlorentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
Dyslipidaemia, hypercoagulability and the metabolic syndromeKakafika, A. I.; Liberopoulos, E. N.; Karagiannis, A.; Athyros, V. G.; Mikhailidis, D. P.24-Nov-2015-
Dyslipidemia in patients with thyroid disordersLiberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-